Welcome to The Myeloma Minutes. This is a living library of credible information for patients of multiple myeloma and their caregivers.

Doctors Jam and Sally treat and speak with patients and caregivers daily. During this episode they talk about the most common and biggest questions they are asked, including:

• What is Myeloma? Is Multiple Myeloma different?
• Where does this type of cancer start?
• How could is possibly be best NOT to treat my myeloma?

This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns

ABOUT YOUR HOSTS

Dr. Jam Kothari

Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.

Dr. Sally Moore

Dr Sally Moore undertook her specialist registrar training in haematology training at University College London Hospital where she undertook a clinical fellow post in myeloma working with Professor Kwee Yong. Upon relocation to Bath in 2013 she established a specialist myeloma service and in 2018 she also joined the myeloma team at the Churchill Hospital Oxford and currently co-chairs the Thames Valley MDT. In spring 2023 she will be taking up the Myeloma Clinical Lead post at University Hospital Bristol.

In 2015 Dr Moore established the Southwest Myeloma Group, she is clinical co-lead for the Myeloma NIHR Health Information Collaborative (HIC) founded in 2021 with support from Myeloma UK which is the first step in establishing a nationwide myeloma registry. She is a member of the UKMRA and is PI on a wide portfolio of clinical trials.

Welcome to The Myeloma Minutes. This is a living library of credible information for patients of multiple myeloma and their caregivers.

During this introductory episode you'll meet your hosts Jam and Sally and hear about their plans for the upcoming episodes, which will cover the following topics (and plenty more besides):

• The basics of myeloma

• Latest treatments, including immunotherapy and clinical trials

• Managing treatment toxicities and side effects

• Patient experiences and quality of life

• Real-time updates on new drug approvals

This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns

ABOUT YOUR HOSTS

Dr. Jam Kothari

Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.

Dr. Sally Moore

Dr Sally Moore undertook her specialist registrar training in haematology training at University College London Hospital where she undertook a clinical fellow post in myeloma working with Professor Kwee Yong. Upon relocation to Bath in 2013 she established a specialist myeloma service and in 2018 she also joined the myeloma team at the Churchill Hospital Oxford and currently co-chairs the Thames Valley MDT. In spring 2023 she will be taking up the Myeloma Clinical Lead post at University Hospital Bristol.

In 2015 Dr Moore established the Southwest Myeloma Group, she is clinical co-lead for the Myeloma NIHR Health Information Collaborative (HIC) founded in 2021 with support from Myeloma UK which is the first step in establishing a nationwide myeloma registry. She is a member of the UKMRA and is PI on a wide portfolio of clinical trials.